MetLife Investment Management’s Shattuck Labs STTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
+37,420
New +$233K ﹤0.01% 2288
2024
Q4
– Sell
-24,596
Closed -$85.8K – 2856
2024
Q3
$85.8K Buy
24,596
+13,859
+129% +$51.7K ﹤0.01% 2685
2024
Q2
$41.4K Buy
+10,737
New +$87.3K ﹤0.01% 2787
2021
Q4
– Sell
-10,943
Closed -$223K – 2550
2021
Q3
$223K Hold
10,943
– – ﹤0.01% 2021
2021
Q2
$317K Buy
10,943
+4,758
+77% +$139K ﹤0.01% 1849
2021
Q1
$181K Hold
6,185
– – ﹤0.01% 2108
2020
Q4
$324K Buy
+6,185
New +$199K ﹤0.01% 1715

Other funds holding STTK

MetLife Investment Management's STTK Position: Q2 2026 in Review

MetLife Investment Management opened a new position in Shattuck Labs (STTK) in Q2 2026: 37,420 shares worth $260K. The stake represents ﹤0.01% of the portfolio and ranks #2288 among its holdings. This is a return to the name: MetLife Investment Management previously reported a position in STTK as recently as Q3 2024.

MetLife Investment Management first reported a position in STTK in Q4 2020 and has held it in 7 quarters since. The position peaked at $324K in Q4 2020. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • MetLife Investment Management held 37,420 shares of Shattuck Labs worth $260K as of Q2 2026.
  • Shattuck Labs was a new MetLife Investment Management position in Q2 2026.
  • Shattuck Labs made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2288 holding.
  • MetLife Investment Management first reported a position in Shattuck Labs in Q4 2020 and has held it in 7 quarters since.
  • MetLife Investment Management's Shattuck Labs position peaked at $324K in Q4 2020.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.